HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women

HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women

Background: Breast cancer in very young women (BCVY) defined as &lt;35 years old, presents with different molecular biology than in older patients. High <i>HDAC5</i> expression has been associated with poor prognosis in breast cancer (BC) tissue. We aimed to analyze <i>HDAC5<...

Full description

Bibliographic Details
Main Authors: Sara S. Oltra, Juan Miguel Cejalvo, Eduardo Tormo, Marta Albanell, Ana Ferrer, Marta Nacher, Begoña Bermejo, Cristina Hernando, Isabel Chirivella, Elisa Alonso, Octavio Burgués, Maria Peña-Chilet, Pilar Eroles, Ana Lluch, Gloria Ribas, María Teresa Martinez
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Cancers
Subjects:
breast cancer
young women
histone deacetylase
hdac5 inhibitors
lmk-235
Online Access:https://www.mdpi.com/2072-6694/12/2/412

Internet

https://www.mdpi.com/2072-6694/12/2/412

Similar Items